A Multicenter, Randomized, Double-blind, Placebo-controlled Dose-finding Phase 2 Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Nov 2016
At a glance
- Drugs YH 12852 (Primary)
- Indications Dyspepsia
- Focus Therapeutic Use
- Sponsors Yuhan
- 27 Oct 2016 Planned End Date changed from 1 Sep 2016 to 1 Jan 2017.
- 27 Oct 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Jan 2017.
- 27 Oct 2016 Status changed from suspended to active, no longer recruiting.